Cited by 11014-3-3 protein interactionsProtein Kinase Regulation and GTPase SignalingProtein Structure and Dynamics

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Discovery and structural characterization of a small molecule 14-3-3 protein-protein interaction inhibitor

Open access

Zhao, Jing, Du, Yuhong, Horton, John R., Upadhyay, Anup K., Lou, Bin, Bai, Yan, Zhang, Xing, Du, Lupei, Li, Minyong, Wang, Binghe, Zhang, Lixin, Barbieri, Joseph T., Khuri, Fadlo R., Cheng, Xiaodong, Fu, Haian·2011·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.1100012108PMC PMC3182712

Open this paper in CoChat — free account

Abstract

The 14-3-3 family of phosphoserine/threonine-recognition proteins engage multiple nodes in signaling networks that control diverse physiological and pathophysiological functions and have emerged as promising therapeutic targets for such diseases as cancer and neurodegenerative disorders. Thus, small molecule modulators of 14-3-3 are much needed agents for chemical biology investigations and therapeutic development. To analyze 14-3-3 function and modulate its activity, we conducted a chemical screen and identified 4-[(2Z)-2-[4-formyl-6-methyl-5-oxo-3-(phosphonatooxymethyl)pyridin-2-ylidene]hydrazinyl]benzoate as a 14-3-3 inhibitor, which we termed FOBISIN (FOurteen-three-three BInding Small molecule INhibitor) 101. FOBISIN101 effectively blocked the binding of 14-3-3 with Raf-1 and proline-rich AKT substrate, 40 kD a and neutralized the ability of 14-3-3 to activate exoenzyme S ADP-ribosyltransferase. To provide a mechanistic basis for 14-3-3 inhibition, the crystal structure of 14-3-3 ζ in complex with FOBISIN101 was solved. Unexpectedly, the double bond linking the pyridoxal-phosphate and benzoate moieties was reduced by X-rays to create a covalent linkage of the pyridoxal-phosphate moiety to lysine 120 in the binding groove of 14-3-3, leading to persistent 14-3-3 inactivation. We suggest that FOBISIN101-like molecules could be developed as an entirely unique class of 14-3-3 inhibitors, which may serve as radiation-triggered therapeutic agents for the treatment of 14-3-3-mediated diseases, such as cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.1100012108

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse‐Kunstleve, R. W., Jiang, J., Kuszewski, J. J., Nilges, M., Pannu, N., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,723
Improved methods for building protein models in electron density maps and the location of errors in these models
Jones, T. A., Zou, J.-Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,616
PRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,837
The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity
Yaffe, M. B., Rittinger, K., Volinia, S., Caron, P. R., Aitken, A., Leffers, H. C. B., Gamblin, S. J., Smerdon, S. J., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)80487-0 · Cited by 1,604
14-3-3 Proteins: Structure, Function, and Regulation
Fu, H., Subramanian, R. R., & Masters, S. C. (2000) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.617 · Cited by 1,596
Self-citation
Interaction of 14-3-3 with Signaling Proteins Is Mediated by the Recognition of Phosphoserine
Muslin, A. J., Tanner, J. W., Allen, P. M., & Shaw, A. S. (1996) · Cell · doi:10.1016/s0092-8674(00)81067-3 · Cited by 1,385
Likelihood-enhanced fast rotation functions
Storoni, L. C., McCoy, A. J., & Read, R. J. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444903028956 · Cited by 1,177
14-3-3 proteins: A historic overview
Aitken, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.005 · Cited by 842
Crystal structure of the zeta isoform of the 14-3-3 protein
Liu, D., Bienkowska, J. R., Petosa, C., Collier, R. J., Fu, H., & Liddington, R. (1995) · Nature · doi:10.1038/376191a0 · Cited by 526
Self-citation

Show all 38 references

Sorted by citations

Modulators of Protein–Protein Interactions
Milroy, L.-G., Grossmann, T. N., Hennig, S., Brunsveld, L., & Ottmann, C. (2014) · Chemical Reviews · doi:10.1021/cr400698c · Cited by 497
The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein–protein interactions
Pennington, K. L., Ty, C., Torres, M. P., & Andersen, J. (2018) · Oncogene · doi:10.1038/s41388-018-0348-3 · Cited by 383
Readout of Epigenetic Modifications
Patel, D. J., & Wang, Z. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-072711-165700 · Cited by 324
Oncogenic protein interfaces: small molecules, big challenges
Nero, T. L., Morton, C. J., Holien, J. K., Wielens, J., & Parker, M. W. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3690 · Cited by 312
Modulators of 14-3-3 Protein–Protein Interactions
Stevers, L. M., Sijbesma, E., Botta, M., MacKintosh, C., Obšil, T., Landrieu, I., Cau, Y., Wilson, A. J., Karawajczyk, A., Eickhoff, J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00574 · Cited by 295
The role of the 14-3-3 protein family in health, disease, and drug development
Aghazadeh, Y., & Papadopoulos, V. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.09.012 · Cited by 258
Molecular tweezers modulate 14-3-3 protein–protein interactions
Bier, D., Rose, R., Bravo‐Rodriguez, K., Bartel, M., Ramírez‐Anguita, J. M., Dutt, S., Wilch, C., Klärner, F., Sánchez‐García, E., Schrader, T. H., et al. (2013) · Nature Chemistry · doi:10.1038/nchem.1570 · Cited by 196
14-3-3 proteins as potential therapeutic targets
Zhao, J., Meyerkord, C. L., Du, Y., Khuri, F. R., & Fu, H. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.09.012 · Cited by 163
Self-citation
Structural insights into the functional roles of 14-3-3 proteins
Obšilová, V., & Obšil, T. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1016071 · Cited by 129
Site-Directed Fragment-Based Screening for the Discovery of Protein–Protein Interaction Stabilizers
Sijbesma, E., Hallenbeck, K. K., Leysen, S., de Vink, P. J., Skóra, L., Jahnke, W., Brunsveld, L., Arkin, M. R., & Ottmann, C. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b11658 · Cited by 110
New Frontiers in Druggability
Kozakov, D., Hall, D. R., Napoleon, R. L., Yueh, C., Whitty, A., & Vajda, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00586 · Cited by 111
A Binary Bivalent Supramolecular Assembly Platform Based on Cucurbit[8]uril and Dimeric Adapter Protein 14‐3‐3
de Vink, P. J., Briels, J. M., Schrader, T. H., Milroy, L. ‐., Brunsveld, L., & Ottmann, C. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201701807 · Cited by 90
Stabilization and Inhibition of Protein–Protein Interactions: The 14-3-3 Case Study
Milroy, L.-G., Brunsveld, L., & Ottmann, C. (2013) · ACS Chemical Biology · doi:10.1021/cb300599t · Cited by 88
Structure, Function, Involvement in Diseases and Targeting of 14-3-3 Proteins: An Update
Cau, Y., Valensin, D., Mori, M., Draghi, S., & Botta, M. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170426095015 · Cited by 85
Synergistic Binding of the Phosphorylated S233- and S259-Binding Sites of C-RAF to One 14-3-3ζ Dimer
Molzan, M., & Ottmann, C. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.08.009 · Cited by 88
G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions
Jacobson, K. A., Balasubramanian, R., Deflorian, F., & Gao, Z. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9294-7 · Cited by 86
Tyrosine and tryptophan hydroxylases as therapeutic targets in human disease
Waløen, K., Kleppe, R., Martı́nez, A., & Haavik, J. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1272581 · Cited by 85
Small-molecule inhibitors that disrupt the MTDH–SND1 complex suppress breast cancer progression and metastasis
Shen, M., Wei, Y., Kim, H., Wan, L., Jiang, Y., Hang, X., Raba, M., Remiszewski, S., Rowicki, M., Wu, C.-G., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00279-5 · Cited by 83
Self-citation
Involvement of 14‐3‐3 in tubulin instability and impaired axon development is mediated by Tau
Joo, Y., Schumacher, B., Landrieu, I., Bartel, M., Smet‐Nocca, C., Jang, A., Choi, H. S., Jeon, N. L., Chang, K., Kim, H., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-265009 · Cited by 81
Small molecule modulators of protein-protein interactions: selected case studies
Aeluri, M., Chamakuri, S., Dasari, B., Guduru, S. K. R., Jimmidi, R., Jogula, S., & Arya, P. (2014) · Chemical Reviews · doi:10.1021/cr4004049 · Cited by 79
14-3-3 Proteins: Novel Pharmacological Targets in Neurodegenerative Diseases
Pair, F. S., & Yacoubian, T. A. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.01.001 · Cited by 74
S6K2: The Neglected S6 Kinase Family Member
Pardo, O. E., & Seckl, M. J. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00191 · Cited by 78
Structure-based evolution of a promiscuous inhibitor to a selective stabilizer of protein–protein interactions
Sijbesma, E., Visser, E., Plitzko, K., Thiel, P., Milroy, L.-G., Kaiser, M., Brunsveld, L., & Ottmann, C. (2020) · Nature Communications · doi:10.1038/s41467-020-17741-0 · Cited by 72
Order by disorder in plant signaling
Kragelund, B. B., Jensen, M. K., & Skriver, K. (2012) · Trends in Plant Science · doi:10.1016/j.tplants.2012.06.010 · Cited by 72
Rho GTPases and cancer
Li, H., Peyrollier, K., Kilic, G., & Brakebusch, C. (2013) · BioFactors · doi:10.1002/biof.1155 · Cited by 63
Structural interface between LRRK2 and 14-3-3 protein
Stevers, L. M., de Vries, R. M. J. M., Doveston, R. G., Milroy, L. ‐., Brunsveld, L., & Ottmann, C. (2017) · Biochemical Journal · doi:10.1042/bcj20161078 · Cited by 59
Direct and Propagated Effects of Small Molecules on Protein–Protein Interaction Networks
Cesa, L. C., Mapp, A. K., & Gestwicki, J. E. (2015) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2015.00119 · Cited by 63
An Optimised Small‐Molecule Stabiliser of the 14‐3‐3–PMA2 Protein–Protein Interaction
Richter, A. M., Rose, R., Hedberg, C., Waldmann, H., & Ottmann, C. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201103761 · Cited by 55
The overexpression of 14‐3‐3ζ and Hsp27 promotes non–small cell lung cancer progression
Zhao, G., Ding, J., Gu, J., Lu, C., Lin, Z., Guo, J., & Ge, D. (2013) · Cancer · doi:10.1002/cncr.28452 · Cited by 52
Thymoquinone Blocks pSer/pThr Recognition by Plk1 Polo-Box Domain As a Phosphate Mimic
Yin, Z., Song, Y., & Rehse, P. H. (2012) · ACS Chemical Biology · doi:10.1021/cb3004379 · Cited by 50
Protein–Protein Interactions as Drug Targets
Skwarczynska, M., & Ottmann, C. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.138 · Cited by 52
Virtual screening and experimental validation reveal novel small-molecule inhibitors of 14-3-3 protein–protein interactions
Thiel, P., Röglin, L., Meissner, N., Hennig, S., Kohlbacher, O., & Ottmann, C. (2013) · Chemical Communications · doi:10.1039/c3cc44612c · Cited by 47
Small-molecule modulators of 14-3-3 protein–protein interactions
Ottmann, C. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.11.028 · Cited by 46
Identification of Two Secondary Ligand Binding Sites in 14-3-3 Proteins Using Fragment Screening
Sijbesma, E., Skóra, L., Leysen, S., Brunsveld, L., Koch, U., Nußbaumer, P., Jahnke, W., & Ottmann, C. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00153 · Cited by 46
Targeting 14-3-3zeta in cancer therapy
Yang, X., Cao, W., Zhang, L., Zhang, W., Zhang, X., & Lin, H. (2011) · Cancer Gene Therapy · doi:10.1038/cgt.2011.85 · Cited by 46
Self-citation
Intracellular Generation of a Diterpene-Peptide Conjugate that Inhibits 14-3-3-Mediated Interactions
Parvatkar, P. T., Kato, N., Uesugi, M., Sato, S., & Ohkanda, J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b09817 · Cited by 42
Rac1 Activation Driven by 14-3-3ζ Dimerization Promotes Prostate Cancer Cell-Matrix Interactions, Motility and Transendothelial Migration
Goc, A., Abdalla, M., Al‐Azayzih, A., & Somanath, P. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040594 · Cited by 41
Destabilisation of dimeric 14-3-3 proteins as a novel approach to anti-cancer therapeutics
Woodcock, J. M., Coolen, C., Goodwin, K. L., Baek, D. J., Bittman, R., Samuel, M. S., Pitson, S. M., & Lopez, A. F. (2015) · Oncotarget · doi:10.18632/oncotarget.3995 · Cited by 39
Structural insights of the MLF1/14‐3‐3 interaction
Molzan, M., Weyand, M., Rose, R., & Ottmann, C. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08445.x · Cited by 37
Small molecules that target phosphorylation dependent protein–protein interaction
Watanabe, N., & Osada, H. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.03.023 · Cited by 37
Discovery of Small-Molecule Stabilizers of 14-3-3 Protein–Protein Interactions via Dynamic Combinatorial Chemistry
Hartman, A. M., Elgaher, W. A. M., Hertrich, N., Andrei, S. A., Ottmann, C., & Hirsch, A. K. H. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00541 · Cited by 36
Molecular insight into specific 14-3-3 modulators: Inhibitors and stabilisers of protein–protein interactions of 14-3-3
Hartman, A. M., & Hirsch, A. K. H. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.04.058 · Cited by 35
A Time-Resolved Fluorescence Resonance Energy Transfer Assay for High-Throughput Screening of 14-3-3 Protein–Protein Interaction Inhibitors
Du, Y., Fu, R. W., Lou, B., Zhao, J., Qui, M., Khuri, F. R., & Fu, H. (2013) · Assay and Drug Development Technologies · doi:10.1089/adt.2013.507 · Cited by 34
Self-citation
Chemical ligation of epoxide-containing fusicoccins and peptide fragments guided by 14-3-3 protein
Maki, T., Kawamura, A., Kato, N., & Ohkanda, J. (2012) · Molecular BioSystems · doi:10.1039/c2mb25388g · Cited by 31
Small molecules modulation of 14-3-3 protein–protein interactions
Mori, M., Vignaroli, G., & Botta, M. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.10.001 · Cited by 30
Influence of Spacer–Receptor Interactions on the Stability of Bivalent Ligand–Receptor Complexes
Numata, J., Juneja, A., Diestler, D. J., & Knapp, E. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp211383s · Cited by 29
Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery
Chen, H., Wu, J., Gao, Y., Chen, H., & Zhou, J. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160216155556 · Cited by 29
Small Molecules, Peptides and Natural Products: Getting a Grip on 14-3-3 Protein–Protein Modulation
Bartel, M., Schäfer, A., Stevers, L. M., & Ottmann, C. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.47 · Cited by 28
Molecular glues of the regulatory ChREBP/14-3-3 complex protect beta cells from glucolipotoxicity
Katz, L. S., Visser, E. J., Plitzko, K., Pennings, M. A. M., Cossar, P. J., Tse, I., Kaiser, M., Brunsveld, L., Ottmann, C., & Scott, D. K. (2025) · Nature Communications · doi:10.1038/s41467-025-57241-7 · Cited by 28
A Binary Bivalent Supramolecular Assembly Platform Based on Cucurbit[8]uril and Dimeric Adapter Protein 14‐3‐3
de Vink, P. J., Briels, J. M., Schrader, T. H., Milroy, L. ‐., Brunsveld, L., & Ottmann, C. (2017) · Angewandte Chemie · doi:10.1002/ange.201701807 · Cited by 28
The Multifarious Role of 14-3-3 Family of Proteins in Viral Replication
Nathan, K. G., & Lal, S. K. (2020) · Viruses · doi:10.3390/v12040436 · Cited by 29
Fusicoccin: A Chemical Modulator for 14-3-3 Proteins
Ohkanda, J. (2020) · Chemistry Letters · doi:10.1246/cl.200670 · Cited by 25
The combination of hydrogen/deuterium exchange or chemical cross-linking techniques with mass spectrometry: Mapping of human 14-3-3ζ homodimer interface
Haladová, K., Mrázek, H., Ječmen, T., Halada, P., Man, P., Novák, P., Chmelík, J., Obšil, T., & Šulc, M. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.04.016 · Cited by 25
Scaffold Functions of 14-3-3 Adaptors in B Cell Immunoglobulin Class Switch DNA Recombination
Lam, T., Thomas, L. M. B., White, C. A., Li, G., Pone, E. J., Xu, Z., & Casali, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080414 · Cited by 25
X-ray Structures of Target–Ligand Complexes Containing Compounds with Assay Interference Potential
Gilberg, E., Gütschow, M., & Bajorath, J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01780 · Cited by 23
Accurate Detection of Adenylation Domain Functions in Nonribosomal Peptide Synthetases by an Enzyme-linked Immunosorbent Assay System Using Active Site-directed Probes for Adenylation Domains
Ishikawa, F., Miyamoto, K., Konno, S., Kasai, S., & Kakeya, H. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00595 · Cited by 22
Versatility of 14-3-3 proteins and their roles in bone and joint-related diseases
Zhou, R., Hu, W., Ma, P. X., & Liu, C.-J. (2024) · Bone Research · doi:10.1038/s41413-024-00370-4 · Cited by 22
Molecular Dynamics Investigations Suggest a Non-specific Recognition Strategy of 14-3-3σ Protein by Tweezer: Implication for the Inhibition Mechanism
Shi, M., & Xu, D. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00237 · Cited by 21
Raf‐interactome in tuning the complexity and diversity of Raf function
An, S., Yang, Y., Ward, R. J., Liu, Y., Guo, X., & Xu, T. (2014) · FEBS Journal · doi:10.1111/febs.13113 · Cited by 20
Rational Design, Binding Studies, and Crystal‐Structure Evaluation of the First Ligand Targeting the Dimerization Interface of the 14‐3‐3ζ Adapter Protein
Ehlers, M., Grad, J., Mittal, S., Bier, D., Mertel, M., Ohl, L., Bartel, M., Briels, J. M., Heimann, M., Ottmann, C., et al. (2017) · ChemBioChem · doi:10.1002/cbic.201700588 · Cited by 20
Revealing the binding modes and the unbinding of 14-3-3σ proteins and inhibitors by computational methods
Hu, G., Cao, Z., Xu, S., Wang, W., & Wang, J. (2015) · Scientific Reports · doi:10.1038/srep16481 · Cited by 19
Covalent attachment of pyridoxal-phosphate derivatives to 14-3-3 proteins
Röglin, L., Thiel, P., Kohlbacher, O., & Ottmann, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116592109 · Cited by 19
14‐3‐3 Family of Proteins: Biological Implications, Molecular Interactions, and Potential Intervention in Cancer, Virus and Neurodegeneration Disorders
Low, Z. Y., Yip, A. J. W., Chan, A. M. L., & Choo, W. S. (2024) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30624 · Cited by 20
Usnic Acid Targets 14-3-3 Proteins and Suppresses Cancer Progression by Blocking Substrate Interaction
Varlı, M., Bhosle, S. R., Kim, E., Yang, Y., Taş, İ., Zhou, R., Pulat, S., Gamage, C. D. B., Park, S., Ha, H., et al. (2024) · JACS Au · doi:10.1021/jacsau.3c00774 · Cited by 18
A pan-respiratory antiviral chemotype targeting a transient host multi-protein complex
Michon, M., Müller‐Schiffmann, A., Lingappa, A. F., Yu, S. F., Du, L., Deiter, F., Broce, S., Mallesh, S., Crabtree, J. M., Lingappa, U. F., et al. (2024) · Open Biology · doi:10.1098/rsob.230363 · Cited by 13
Self-citation
14-3-3γ affects mTOR pathway and regulates lactogenesis in dairy cow mammary epithelial cells
Khudhair, N., Luo, C., Khalid, A., Zhang, L., Zhang, S., Ao, J., Li, Q., & Gao, X. (2015) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-015-9879-x · Cited by 13
Self-citation
Integrate Omics Data and Molecular Dynamics Simulations toward Better Understanding of Human 14-3-3 Interactomes and Better Drugs for Cancer Therapy
Babula, J. J., & Liu, J. (2015) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.09.002 · Cited by 12
14–3-3 protein and its isoforms: A common diagnostic marker for Alzheimer’s disease, Parkinson’s disease and glaucomatous neurodegeneration
Panda, S. P., Kesharwani, A., Singh, B., Marisetti, A. L., Chaitanya, M., Dahiya, S., Ponnusankar, S., Kumar, S., Singh, M., Shakya, P. K., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102572 · Cited by 12
The Application of an Emerging Technique for Protein–Protein Interaction Interface Mapping: The Combination of Photo-Initiated Cross-Linking Protein Nanoprobes with Mass Spectrometry
Ptáčková, R., Ječmen, T., Novák, P., Hudeček, J., Stiborová, M., & Šulc, M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069224 · Cited by 11
Disruption of Protein-Protein Interfaces
Mangani, S. (2013) · Springer eBooks · doi:10.1007/978-3-642-37999-4 · Cited by 11
Mono‐ and Bivalent 14‐3‐3 Inhibitors for Characterizing Supramolecular “Lysine Wrapping” of Oligoethylene Glycol (OEG) Moieties in Proteins
Yilmaz, E., Bier, D., Guillory, X., Briels, J. M., Ruiz‐Blanco, Y. B., Sánchez‐García, E., Ottmann, C., & Kaiser, M. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201801074 · Cited by 11
Copper‐Free Huisgen Cycloaddition for the 14‐3‐3‐Templated Synthesis of Fusicoccin‐Peptide Conjugates
Masuda, R., Kawasaki, Y., Igawa, K., Manabe, Y., Fujii, H., Kato, N., Tomooka, K., & Ohkanda, J. (2020) · Chemistry - An Asian Journal · doi:10.1002/asia.202000042 · Cited by 11
Cellular Target Proteome in Breast Cancer Cells of an Oplopane Sesquiterpenoid Isolated fromTussilago farfara
Song, K., Nho, C. W., Ha, I. J., & Kim, Y. S. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.0c00043 · Cited by 10
Elucidating the Molecular Basis of 14–3–3 Interaction with α-Synuclein: Insights from Molecular Dynamics Simulations and the Design of a Novel Protein–Protein Interaction Inhibitor
Chakraborty, G., & Patra, N. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c01743 · Cited by 9
Modelling cellular signal communication mediated by phosphorylation dependent interaction with 14‐3‐3 proteins
Kleppe, R., Ghorbani, S., Martı́nez, A., & Haavik, J. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.11.012 · Cited by 9
The effect of an engineered ATCUN motif on the structure and biophysical properties of the SH3 domain of c-Src tyrosine kinase
Plaza-Garrido, M., Salinas-García, M. C., Martínez, J. C., & Cámara-Artigas, A. (2020) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-020-01785-0 · Cited by 7
Small molecule microarray screening methodology based on surface plasmon resonance imaging
Singh, V., Singh, K., Nand, A., Dai, H., Wang, J., Zhang, L., Merino, A., & Zhu, J. (2015) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2014.12.020 · Cited by 7
Self-citation
[Analysis of differentially expressed proteome in urine from non-small cell lung cancer patients].
Chen, Z., Liu, J., Lin, L., Xie, H., Zhang, W., Zhang, H., & Wang, G. (2015) · Europe PMC (PubMed Central) · doi:10.3779/j.issn.1009-3419.2015.03.03 · Cited by 7
Discovery of an allosteric 14-3-3 inhibitor for suppressing NRF2-driven cancer via phenotypic screening and chemoproteomic-based target deconvolution
Zhao, J., Jiang, H., Zhao, K., Liu, T., Zhang, Q., Zhao, Z., Wang, J., You, Q., Lu, M., & Jiang, Z. (2025) · Chemical Science · doi:10.1039/d5sc04324g · Cited by 5
Self-citation
Optimizing Phosphopeptide Structures That Target 14-3-3ε in Cutaneous Squamous Cell Carcinoma
Kamayirese, S., Maity, S., Dieckman, L. M., Hansen, L. A., & Lovas, S. (2024) · ACS Omega · doi:10.1021/acsomega.3c07740 · Cited by 5
The Effect of 5'-Adenylic Acid on Hepatic Proteome of Mice Radiated by 60Co γ-ray
Cheng, C., Zhao, H., Wang, Z., Lu, W., Wang, L., Wang, R., & Yao, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms15010186 · Cited by 4
Protein–Protein Interaction Inhibitors in Cancer
Hardcastle, I. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12392-3 · Cited by 5
The International Chemical Biology Community Synthesizes a New Society
Johns, M. A. (2012) · ACS Chemical Biology · doi:10.1021/cb200507f · Cited by 4
Small-molecule Modulators of Protein–Protein Interactions: Focus on 14-3-3 PPIs
Iralde-Lorente, L., Botta, M., & Ottmann, C. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016544-00249 · Cited by 3
Discovery of a Plant 14‐3‐3 Inhibitor Possessing Isoform Selectivity and In Planta Activity
Nishiyama, K., Aihara, Y., Suzuki, T., Takahashi, K. U., Kinoshita, T., Dohmae, N., Sato, A., & Hagihara, S. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202400218 · Cited by 3
PAR-5is a PARty hub in the germline
Aristizábal-Corrales, D., Schwartz, S., & Cerón, J. (2013) · Worm · doi:10.4161/worm.21834 · Cited by 3
Subnetwork estimation for spatial autoregressive models in large-scale networks
Li, X., Wang, F., Lan, W., & Wang, H. (2023) · Electronic Journal of Statistics · doi:10.1214/23-ejs2139 · Cited by 2
Recent Trends in Development of Novel Therapeutics for Modulation of 14-3-3 Protein-Protein Interactions in Diseases
Nazir, A. (2024) · Protein and Peptide Letters · doi:10.2174/0109298665330728241025082011 · Cited by 2
14-3-3γ affects eIF5 to regulate β-casein synthesis in bovine mammary epithelial cells
Yu, C., Luo, C., Gu, X., Zang, Y., Qu, B., Khudhair, N., Li, Q., & Gao, X. (2016) · Canadian Journal of Animal Science · doi:10.1139/cjas-2016-0038 · Cited by 2
Proteome Analysis of Drosophila Mutants Identifies a Regulatory Role for 14–3–3ε in Metabolic Pathways
Ng, Y., Sorvina, A., Bader, C. A., Weiland, F., Lopez, A. F., Hoffmann, P., Shandala, T., & Brooks, D. A. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b01032 · Cited by 2
Reply to Röglin et al.: Synchrotron radiation-induced covalent modification of 14-3-3ζ by diazene compounds containing pyridoxal phosphate
Upadhyay, A. K., Horton, J. R., Du, Y., Bai, Y., Cheng, X., & Fu, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203341109 · Cited by 2
Self-citation
Dual Allosteric and Orthosteric Inhibition of 14‐3‐3ζ–α‐Synuclein Interaction: A Multiscale Simulation and Machine Learning Approach
Chakraborty, G., Chaudhary, A., & Patra, N. (2025) · Advanced Theory and Simulations · doi:10.1002/adts.202501455 · Cited by 1
Fluorescence Observables and Enzyme Kinetics in the Investigation of PPI Modulation by Small Molecules: Detection, Mechanistic Insight, and Functional Consequences
Ponterini, G. (2013) · Springer eBooks · doi:10.1007/978-3-642-37999-4_6 · Cited by 1
Exploring the Binding Mechanism of a Supramolecular Tweezer CLR01 to 14-3-3σ Protein via Well-Tempered Metadynamics
Zhou, X., Shi, M., Wang, X., & Xu, D. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.921695 · Cited by 1
Small-Molecule Inhibitors of Protein–Protein Interactions as Therapeutics
Poluri, K. M., Gulati, K., Tripathi, D. K., & Nagar, N. (2023) · Springer eBooks · doi:10.1007/978-981-99-2423-3_7 · Cited by 1
Discovery of a Plant 14‐3‐3 Inhibitor Possessing Isoform Selectivity and In Planta Activity
Nishiyama, K., Aihara, Y., Suzuki, T., Takahashi, K. U., Kinoshita, T., Dohmae, N., Sato, A., & Hagihara, S. (2024) · Angewandte Chemie · doi:10.1002/ange.202400218 · Cited by 1
High Throughput Screening Methods for PPI Inhibitor Discovery
Doyle, S. P., Mo, X., Qian, K., Cicka, D., Niu, Q., & Fu, H. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016544-00049 · Cited by 1
Self-citation
The design and synthesis of peptidomimetic serine-based prodrugs as 14-3-3 inhibitors
Jones, E. D. (2013) · Purdue e-Pubs (Purdue University System)
Kinetic characterization of VopT, a mono-ADP-ribosyltransferase toxin from Vibrio parahaemolyticus
Poole, A. (2016) · The Atrium (University of Guelph)
Regulation of subcellular localization of lipid phosphatase SAC1
Wang, J. (2016) · doi:10.6083/m4gm85bz

Authors: Zhao, J., Du, Y., Horton, J. R., Upadhyay, A. K., Lou, B., Bai, Y., Zhang, X., Du, L., Li, M., Wang, B., Zhang, L., Barbieri, J. T., Khuri, F. R., Cheng, X., & Fu, H.
Affiliations: Air Force Medical University (CN)
Emory University (US)
Biochemistry; and
Departments of Pharmacology;
Department of Chemistry, Georgia State University, Atlanta, GA 30302;
Georgia State University (US)
Chinese Academy of Sciences (CN)
Medical College of Wisconsin (US)
Hematology and Medical Oncology;
ORCID: Zhao, Jing
Horton, John R.
Upadhyay, Anup K.
Zhang, Xing
Li, Minyong
Wang, Binghe
Zhang, Lixin
Barbieri, Joseph T.
Khuri, Fadlo R.
Cheng, Xiaodong
Fu, Haian
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2011-09-09
Volume: 108
Issue: 39
Pages: 16212-16216
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.1100012108
PMC: PMC3182712
OpenAlex: W2156331971
Cited by: 105
References: 38
Citations by year: 2026: 1 · 2025: 4 · 2024: 10 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 10 · 2019: 3 · 2018: 3 · 2017: 9 · 2016: 7 · 2015: 13 · 2014: 6 · 2013: 15 · 2012: 15
FWCI: 5.06
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Emory University
School of Medicine, Emory University
National Cancer Institute (P01CA116676)
National Institute of General Medical Sciences (GM092035, GM068680, RC1GM092035, R01GM068680)
National Institute of Allergy and Infectious Diseases (AI-030162, R01AI030162)
Argonne National Laboratory
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › 14-3-3 protein interactions
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Keywords: 14-3-3 proteins, protein-protein interaction inhibitors, small molecule inhibitors, Raf-1, PRAS40, cancer therapy
MeSH terms: Animals, Chlorocebus aethiops, Enzyme-Linked Immunosorbent Assay, Fluorescence Polarization, Models, Molecular, Protein Binding, Protein Conformation, Crystallography, X-Ray, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, COS Cells, 14-3-3 Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Discovery and structural characterization of a small molecule 14-3-3 protein-protein interaction inhibitor

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks